 |
|
Thrombolysis for Stroke
Thomas Brott, MD
Arch Fam Med. 1997;6(2):101-102.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Activase, Alteplase recombinant for acute ischemic stroke. Presented at the Peripheral and Central Nervous System Drug Advisory Committee Meeting; June 6, 1996; Bethesda, Md.
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
FREE FULL TEXT
3. Hacke W, Kaste M, Fieschi C, et al, for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA. 1995;274:1017-1025.
FREE FULL TEXT
4. Brott T, Haley EC, Levy DE, et al. Urgent therapy for stroke, I: pilot study of tissue plasminogen activator administered within 90 minutes. Stroke. 1992;23:632-640.
FREE FULL TEXT
5. Haley EC, Levy DE, Brott TG, et al. Urgent therapy for stroke, II: pilot study of tissue plasminogen activator (rt-PA) administered 90-108 minutes from onset. Stroke. 1992;23:641-645.
FREE FULL TEXT
6. del Zoppo G, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32:78-86.
PUBMED
7. Taylor TN, Davis PH, Torner JC, Holmes JS, Meyer JW, Jacobson MF. Lifetime cost of stroke in the United States. Stroke. 1996;27:1459-1466.
FREE FULL TEXT
|
